iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
1,934.8
(-1.75%)
Feb 6, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Glenmark Pharmaceuticals Ltd Historical Data

07/01/2026calendar-icon
07/02/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

07-Jan-2026

2,076

2,147.52,070.72,113.154,9772,70,93,26,990.63,77,919

08-Jan-2026

2,122.1

2,122.12,0742,079.840,00986,33,05,594.71,63,489

09-Jan-2026

2,074

2,0791,9972,007.231,74795,66,07,022.41,68,459

12-Jan-2026

2,007.2

2,020.41,967.62,017.523,14469,88,15,485.31,10,481

13-Jan-2026

2,028

2,0281,951.12,008.236,6711,64,97,84,390.92,37,790

14-Jan-2026

2,025

2,041.82,003.32,011.326,4581,04,87,71,405.91,87,822

16-Jan-2026

2,022

2,0281,9902,000.720,87272,81,76,048.21,77,051

19-Jan-2026

1,996

2,007.41,980.31,989.813,06832,02,45,184.953,765

20-Jan-2026

1,980.3

1,989.81,927.41,93529,72680,50,70,647.41,96,877

21-Jan-2026

1,927

1,9601,910.11,941.428,24290,73,95,935.71,43,609

22-Jan-2026

1,955

2,0091,9551,997.224,6511,43,34,11,062.74,70,066

23-Jan-2026

2,000

2,022.91,961.81,967.722,15684,41,36,589.82,05,240

27-Jan-2026

1,968.4

2,0101,967.11,999.735,39291,21,51,789.81,94,410

28-Jan-2026

2,011.5

2,012.11,9801,993.514,94646,30,19,470.41,08,883

29-Jan-2026

2,002.4

2,0221,975.11,985.628,66491,58,95,569.92,03,112

30-Jan-2026

1,978.7

2,026.11,928.82,015.935,3231,10,91,68,901.82,55,737

01-Feb-2026

2,011

2,0111,9291,94018,99474,32,54,911.689,168

02-Feb-2026

1,935.1

1,964.41,8421,920.470,9202,80,60,92,248.97,55,708

03-Feb-2026

1,995

2,006.61,947.61,954.236,9251,05,27,11,914.82,73,449

04-Feb-2026

1,954.2

1,992.11,945.91,959.334,91476,26,05,531.71,81,825

05-Feb-2026

1,955.2

1,976.31,9261,969.334,41778,21,99,2211,65,283

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.